These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2259757)

  • 1. Harmonization of guidelines for toxicity testing of pharmaceuticals by 1992.
    Speid LH; Lumley CE; Walker SR
    Regul Toxicol Pharmacol; 1990 Oct; 12(2):179-211. PubMed ID: 2259757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproductive toxicology guidelines: comparison and application.
    Beltrame D; Mazué G
    Ann Ist Super Sanita; 1993; 29(1):3-14. PubMed ID: 8129269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of documentation requirements for preclinical sections, for marketing submissions in the European Community, Japan and the USA.
    Marr AP; Scales MD
    Adverse Drug React Toxicol Rev; 1993; 12(4):253-62. PubMed ID: 8142578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety assessment of biotechnology-derived pharmaceuticals: ICH and beyond.
    Serabian MA; Pilaro AM
    Toxicol Pathol; 1999; 27(1):27-31. PubMed ID: 10367669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Toxicology animal studies necessary for clinical research and registration of drugs for human use: conclusions of the International Harmonization Conference (I)].
    Rubio Terrés C; Duque I; Tristán C; Galende I
    Med Clin (Barc); 1993 Nov; 101(18):705-16. PubMed ID: 8114529
    [No Abstract]   [Full Text] [Related]  

  • 6. International Conference on Harmonisation: guidance on testing for carcinogenicity of pharmaceuticals. Notice. Food and Drug Administration, HHS.
    Fed Regist; 1998 Feb; 63(35):8983-6. PubMed ID: 12269370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory forum opinion piece*: supporting the need for international harmonization of safety assessments for food flavoring substances.
    Konishi Y; Hayashi SM; Fukushima S
    Toxicol Pathol; 2014 Aug; 42(6):949-53. PubMed ID: 23881932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethical review of regulatory toxicology guidelines involving experiments on animals: the example of endocrine disrupters.
    Purchase IF
    Toxicol Sci; 1999 Dec; 52(2):141-7. PubMed ID: 10630565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotoxicity testing: current practices and strategies used by the pharmaceutical industry.
    Purves D; Harvey C; Tweats D; Lumley CE
    Mutagenesis; 1995 Jul; 10(4):297-312. PubMed ID: 7476265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of recommendations from the International Conference on Harmonization (ICH) for the safety evaluation of new medicines involving animal studies for the pharmaceutical industry.
    Scales MD
    Adverse Drug React Toxicol Rev; 1992; 11(1):5-12. PubMed ID: 1606283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
    Box RJ; Spielmann H
    Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposal for international guidelines for reproductive and developmental toxicity testing for pharmaceuticals.
    Lumley CE
    Adverse Drug React Toxicol Rev; 1991; 10(3):143-53. PubMed ID: 1747441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
    Pflieger M; Bertram D
    Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Animal toxicology studies necessary for clinical research and the registry of drugs for human use: conclusions of the International Conference of Harmonization (and II)].
    Tristán C; Galende I; Rubio Terrés C; Duque I
    Med Clin (Barc); 1994 May; 102(20):791-6. PubMed ID: 7913735
    [No Abstract]   [Full Text] [Related]  

  • 15. Design and international harmonization of pharmacopoeial standards.
    Calam DH
    J Pharm Biomed Anal; 1995 Dec; 14(1-2):1-5. PubMed ID: 8833960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA requirements for nonclinical testing of contraceptive steroids.
    Jordan A
    Contraception; 1992 Dec; 46(6):499-509. PubMed ID: 1493710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Japanese guidelines for mutagenicity testing. Ministry of Agriculture, Forestry and Fisheries; Ministry of Health and Welfare; Ministry of Labor.
    Sofuni T
    Environ Mol Mutagen; 1993; 21(1):2-7; discussion 46-57. PubMed ID: 8419152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harmonization of rules in GLP and pharmacokinetic analysis: regulatory view.
    Grabowski T; Marczak M; Muszynski M; Jaroszewski JJ
    Bioanalysis; 2012 Feb; 4(4):417-30. PubMed ID: 22394142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ICH guidelines--implementation of the 3Rs (refinement, reduction, and replacement): incorporating best scientific practices into the regulatory process.
    Ohno Y
    ILAR J; 2002; 43 Suppl():S95-8. PubMed ID: 12388859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical Toxicity Studies for Regenerative Medicine in Japan.
    Shigeto J; Ichiki T; Nii T; Konno K; Nakanishi Y; Sugiyama D
    Clin Ther; 2018 Nov; 40(11):1813-1822. PubMed ID: 30458928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.